MetaCap

Warby Parker Cash Flow Statement

NYSE: WRBYHealth CareOphthalmic GoodsUSD

25.30+0.35 (+1.40%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Warby Parker free cash flow

In fiscal 2025, Warby Parker generated $110.8 million of operating cash flow and spent $67.0 million on capital expenditures. That left free cash flow of $43.7 million, a free-cash-flow margin of 5.0% of revenue. Free cash flow was up 26.0% from the prior year's $34.7 million.

Summary generated from market data by MetaCap's automated system. Methodology

Warby Parker cash flow statement (annual)

Warby Parker annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income1.64M-20.39M-63.20M-110.39M-144.27M-55.92M0
Net Income growth (YoY)———————
Depreciation & Amortization50.28M45.87M38.55M31.86M21.55M17.76M14.52M
Stock-Based Compensation34.54M47.29M70.51M98.03M107.15M44.91M8.50M
Change in Working Capital11.96M7.82M10.25M-24.93M-32.01M20.22M-5.21M
Operating Cash Flow110.78M98.74M60.99M10.37M-31.99M32.76M21.39M
Capital Expenditures-67.05M-64.03M-53.67M-60.18M-48.51M-20.07M-32.63M
Investing Cash Flow-67.05M-66.03M-54.67M-60.18M-48.51M-20.07M-32.63M
Share Repurchases——00-8.09M0-79.47M
Financing Cash Flow-12.00M4.96M2.87M3.29M23.00M245.94M-83.36M
Net Change in Cash32.20M37.27M8.31M-47.83M-57.67M258.66M-94.36M
Free Cash Flow43.74M34.71M7.32M-49.81M-80.51M12.69M-11.24M

This table shows 7 annual periods of Warby Parker's cash flow statement, from FY 2025 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow WRBY's reporting calendar. What is a cash flow statement?

More financial data